Ledger.Open graph →
SEC Form D · filed October 17, 2025

Biovantix Biotechnology, Inc

Offering
$15.0M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DOVER, DE
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Christian Carnes · Dover, DEExecElena Verutina · Dover, DEExecJack Sunier · Dover, DEExecChristian Carnes · Dover, DEExecJack Sunier · Dover, DEExecElena Verutina · Dover, DEExecPaul J. Carbone · Chicago, ILExecCharles A. Brickman · Chicago, ILExecRandall A. Mehl · Milwaukee, WIExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗